364794-83-2 Usage
Molecular structure
A complex chemical compound with a long molecular structure.
Piperazine ring
Contains a piperazine ring with an ethyl group attached to it.
Benzyl group
Has a benzyl group attached to the piperazine ring.
Boron-containing dioxaborolane group
Contains a heterocyclic compound that contains boron, oxygen, and carbon atoms.
Industrial applications
May have various industrial applications due to the presence of the boron-containing dioxaborolane group.
Pharmaceutical applications
May have pharmaceutical applications due to the presence of the boron-containing dioxaborolane group.
Research applications
May have research applications due to the presence of the boron-containing dioxaborolane group.
Chemical reactions
The boron-containing dioxaborolane group can participate in a variety of chemical reactions and interactions.
Heterocyclic compound
The boron-containing dioxaborolane group is a heterocyclic compound.
Carbon atoms
The boron-containing dioxaborolane group contains carbon atoms.
Oxygen atoms
The boron-containing dioxaborolane group contains oxygen atoms.
Boron atoms
The boron-containing dioxaborolane group contains boron atoms.
Check Digit Verification of cas no
The CAS Registry Mumber 364794-83-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,6,4,7,9 and 4 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 364794-83:
(8*3)+(7*6)+(6*4)+(5*7)+(4*9)+(3*4)+(2*8)+(1*3)=192
192 % 10 = 2
So 364794-83-2 is a valid CAS Registry Number.
364794-83-2Relevant articles and documents
Substituted 4-anilino-7-phenyl-3-quinolinecarbonitriles as Src kinase inhibitors
Berger, Dan,Dutia, Minu,Powell, Dennis,Wissner, Allan,DeMorin, Frenel,Raifeld, Yuri,Weber, Jennifer,Boschelli, Frank
, p. 2989 - 2992 (2007/10/03)
A series of substituted 4-anilino-7-phenyl-3-quinolinecarbonitriles has been prepared as Src kinase inhibitors. Optimal activity is observed with compounds that have basic amines attached via the para position of the 7-phenyl ring, and a hydrogen atom at the C-6 position. The best compounds are low nanomolar inhibitors of Src kinase, and have potent activity against Src-transformed fibroblast cells.